Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 509441 - 509460 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L01EA04) bosutinib (adm: O) | Bosutinib Teva | 28, 100 mg , Blister, 28 tabletter | Retail price without vat |
$0-0 |
$0-0 |
n/a | AbacusMedicineA/S |
| Sweden | (L01EA04) bosutinib (adm: O) | Bosulif® | 28, 100 mg , Blister, 28 tabletter (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | AbacusMedicineA/S |
| Sweden | (L01EA04) bosutinib (adm: O) | Bosulif® | 112, 100 mg , Blister, 112 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | MedartuumAB |
| Sweden | (L01EA04) bosutinib (adm: O) | Bosulif® | 112, 100 mg , Blister, 112 tabletter (PD: 2care4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | 2care4ApS |
| Sweden | (L01EC03) encorafenib (adm: O) | Braftovi | 42, 75 mg , Blister, 42 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PierreFabrePharmaNordenAB |
| Sweden | (L01EC03) encorafenib (adm: O) | Braftovi | 42, 75 mg , Blister, 42 kapslar (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | MedartuumAB |
| Sweden | (L01EC03) encorafenib (adm: O) | Braftovi | 42, 75 mg , Blister, 42 kapslar (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | AbacusMedicineA/S |
| Sweden | (L01EC03) encorafenib (adm: O) | Braftovi | 42, 75 mg , Blister, 42 kapslar (PD: 2care4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | 2care4ApS |
| Sweden | (L01EE03) binimetinib (adm: O) | Mektovi | 84, 15 mg , Blister, 84 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | PierreFabrePharmaNordenAB |
| Sweden | (L01EE03) binimetinib (adm: O) | Mektovi | 84, 15 mg , Blister, 84 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | MedartuumAB |
| Sweden | (L01EE03) binimetinib (adm: O) | Mektovi | 168, 15 mg , Blister, 168 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | PierreFabrePharmaNordenAB |
| Sweden | (L01EE03) binimetinib (adm: O) | Mektovi | 28, 45 mg , Blister, 28 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | PierreFabrePharmaNordenAB |
| Sweden | (L01EE03) binimetinib (adm: O) | Mektovi | 28, 45 mg , Blister, 28 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | MedartuumAB |
| Sweden | (L01EF01) palbociclib (adm: O) | IBRANCE | 21, 100 mg , Blister, 21 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | MedartuumAB |
| Sweden | (L01EF01) palbociclib (adm: O) | IBRANCE | 21, 125 mg , Blister, 21 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | MedartuumAB |
| Sweden | (L01EF01) palbociclib (adm: O) | IBRANCE | 21, 75 mg , Blister, 21 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | MedartuumAB |
| Sweden | (L01EF03) abemaciclib (adm: O) | Verzenios | 168, 50 mg , Blister, 168 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAB |
| Sweden | (L01EJ01) ruxolitinib (adm: O) | Jakavi | 56, 5 mg , Blister, 56 tabletter (PD: Ebb Medical AB) | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | EbbMedicalAB |
| Sweden | (L01EK01) axitinib (adm: O) | Axitinib Sandoz | 56, 5 mg , Blister, 56 tabletter | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozA/S |
| Sweden | (L01EL05) pirtobrutinib (adm: O) | Jaypirca | 56, 100 mg , Blister, 56 tabletter (PD: 2care4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | 2care4ApS |
Pages
